GlassScriptPhysician profile
Frank D Mongiardo
NPI 1619048139
$4,447.64
in general payments reported to CMS, 2019-2025
15 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $1,283 · 2021: $509 · 2022: $779 · 2023: $640 · 2024: $251 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.59 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,454.81 | 2019-2025 | Latera, Scopis Ent, Medpor Contain |
| Olympus America INC. | $959.50 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $519.19 | 2019-2025 | Dupixent |
| Genzyme Corporation | $381.73 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $257.57 | 2019-2025 | Tezspire |
| Glaxosmithkline, LLC. | $236.81 | 2021-2023 | Nucala |
| Aerin Medical INC. | $184.53 | 2023-2024 | |
| Acclarent, INC | $149.03 | 2019-2023 | Acclarent Aera, Acclarent Navwire |
| Optinose US, INC. | $128.06 | 2019-2024 | |
| Amgen INC. | $57.57 | 2025 | Tezspire |
| Lilly USA, LLC | $37.40 | 2025 | Zepbound, Mounjaro |
| Inspire Medical Systems, INC. | $22.04 | 2025 | Inspire |
| Intersect Ent, INC. | $20.62 | 2019 | |
| Uswm, LLC | $20.00 | 2021 | |
| Neurent Medical Limited | $18.78 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Mongiardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.